The FDA has already approved 24 new drugs in 2017. Here's what you need to know about the latest 5.
The drugs might change, but the people never do. Part 2 of our best of the 70s series.
An investigation into Actemra (tocilizumab) has uncovered hundreds of serious adverse drug events, but the drug's labeling has not been changed.
A new study looks at how pharmacists can prevent medication-related admissions.
The agency is trying to deliver on its goal of a 90-day response time.
From a 1970s column, “silly syndrome,” the best customer stories of the decade.
A new BCBS study finds that 21% of insured members filled at least one opioid script in 2015.
After anti-trust woes, the acquisition is thrown out and Walgreens buys over 2,000 stores.
The owner of Indiana-based Pharmakon Pharmaceuticals is charged with distributing adulterated drugs and lying to the FDA.
The NECC tragedy comes to a close as Barry Cadden is sentenced.